The Fault in Our Tests
We share our proposal to collaborate with the AAMC to study the nature of implicit biases in the MCAT and ...
We Need Open Artificial Intelligence
Some people are saying AI will destroy the world, but I think it contributes to the hope of saving the ...
My Dying Wish
I encourage everybody to have a hard discussion with your family and close friends on the subject of dying.
DEA Comments Gaffe
The DEA (Drug Enforcement Agency) has ordained its decree: Another year, another decrease in the production quota for prescription opioids.
Stop Sensationalizing Respiratory Viruses
Instead of using sensationalistic terminology, it would be more helpful to focus on accurate information when discussing respiratory viruses.
Elderly Medical Debt Leads to Financial Ruin
The prospect of dying broke looms for the boomer generation as they face financial hardship due to soaring healthcare costs.
Literature Made Me a Doctor
As a poet and scholar of the health humanities, I stand in the overlapping field of healing and poetic practices.
The Pollution and Alzheimers Connection
People who were exposed to more pollution did worse on cognitive tests, and the outer layer of their brain, the ...
Illegal Immigration Burdens the c
One area that is particularly affected is the American healthcare system, both in terms of financial strain and clinical outcomes.
Mental Health Courts Struggle to Fulfill Mission
Advocates, attorneys, clinicians, and researchers say mental health courts struggle to live up to their promise.
ProPublica Adds Ownership Information to Nursing Home Database
The quality of care that residents receive in a nursing home can be profoundly affected by who owns it, studies ...
Physicians: Write Legal Briefs
In recent years, there has been an increasing need for physicians to participate in complex healthcare legal cases by writing ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more